| ADR Ontology |
| ADR Term |
Helicobacter infection |
| ADR ID |
BADD_A05333 |
| ADR Hierarchy |
|
| Description |
Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease. [MeSH] |
| MedDRA Code |
10054263 |
| MeSH ID |
D016481
|
|
ADR Severity Grade (FAERS)
|
Not Available
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Bacterial infection due to helicobacter pylori (H. pylori) | Helicobacter pylori infection | Helicobacter infection | Helicobacter Infections | Infections, Helicobacter | Helicobacter Infection | Infection, Helicobacter |
|
|
| Drugs Leading to the ADR |
| Drug ID | Drug Name | ADR Frequency (FAERS) | ADR Severity Grade (FAERS) | | BADD_D00410 | Celecoxib | - | - | | BADD_D02254 | Tramadol | - | - |
| The 1th Page 1
Total 1 Pages
|
|
